search
Back to results

Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution

Primary Purpose

Menorrhagia, Dysfunctional Uterine Bleeding, Leiomyoma

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Conventional Laparoscopic Hysterectomy (LH)
Robot Assisted Hysterectomy
Sponsored by
Milton S. Hershey Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Menorrhagia focused on measuring Hysterectomy, Laparoscopy, Robotics

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Individuals recruited into this study will be patients presenting to the Urogynecology and Minimally Invasive Surgical Group for consultation for hysterectomy.

Exclusion Criteria:Individuals who are not candidates for laparoscopic surgery

  • Medical Condition that does not allow pneumoperitoneum
  • Medical Condition that does not allow proper ventilation during anesthesia
  • Uterine size precluding access to the uterine artery
  • Pelvic Organ Prolapse amendable to a vaginal approach

Sites / Locations

  • Penn State Milton S. Hershey Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

LH Group

RH Group

Arm Description

The LH Group includes individuals undergoing conventional laparoscopic hysterectomy, total or supracervical.

The RH Group includes individuals undergoing Robot-Assisted laparoscopic hysterectomy, total or supracervical.

Outcomes

Primary Outcome Measures

Operating Time

Secondary Outcome Measures

Estimated Blood Loss
Intraoperative Complications
Intraoperative complications include: injury to bladder, ureters, bowel, blood vessels,and nerves AND hemorrhage
Perioperative Complications
Perioperative complications include: urinary tract infections, urinary retention, ileus, myocardial infarction, atrial fibrillation, pulmonary edema, atelectasis, pneumonia, renal and cerebrovascular morbidity, thromboembolic complications (DVT and PE)
Early Postoperative Complications
Early postoperative complications include: pulmonary, renal, and cerebrovascular morbidity, wound and vault complications (infection, breakdown, and dehiscence); septicemia, and thromboembolic complications (DVT, PE)
Delayed Post-Operative Complications
Delayed post-operative complications include: incisional hernia formation, re-operation, vaginal evisceration
Costs
Costs will include the costs of pre-operative care, surgery, post-operative care, and any post-operative complications.

Full Information

First Posted
February 24, 2012
Last Updated
January 19, 2017
Sponsor
Milton S. Hershey Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01581905
Brief Title
Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution
Official Title
A Randomized Controlled Trial Comparing Conventional Laparoscopic Hysterectomy With Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Terminated
Why Stopped
Trial was redesigned as a new trial
Study Start Date
March 2012 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Milton S. Hershey Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Approximately 600,000 women undergo hysterectomy each year in the United States, of which 12% are laparoscopic. The most common indications for hysterectomy are: symptomatic uterine leiomyomas (40.7%), endometriosis (17.7%), and prolapse (14.5%). The first total laparoscopic hysterectomy was performed by Reich et al in 1988. Many studies have proven that laparoscopic hysterectomy is associated with lower preoperative morbidity, shorter hospital stay, and shorter recovery times than abdominal hysterectomy. The literature has also shown the complication rates for laparoscopic cases are similar to open procedures in the hands of an experienced laparoscopic surgeon. The American Congress of Obstetricians and Gynecologists Committee on Gynecologic Practice state that laparoscopic hysterectomy is an alternative to abdominal hysterectomy for those patients in whom vaginal hysterectomy is not indicated or feasible. The ACOG Committee on Gynecologic Practice site multiple advantages of laparoscopic hysterectomy to abdominal hysterectomy including faster recovery, shorter hospital stay, less blood loss, and fewer abdominal wall/wound infections. Despite the recommendations of ACOG for a more minimally invasive approach, 66% of all hysterectomies are performed abdominally. Key reasons for the lag in utilization of laparoscopic techniques are the technical obstacles of performing minimally invasive hysterectomies. Robotic technology has emerged as a means to decrease the learning curve and increase the availability of minimally invasive surgery to patients. A current review of the literature reveals no randomized trials evaluating the efficacy of conventional laparoscopic hysterectomy vs. robot-assisted laparoscopic hysterectomy. The investigator's aim is to address this void. The primary objective of this study is to determine whether Robot-Assisted Laparoscopic Hysterectomy is equivalent to Conventional Laparoscopic Hysterectomy with respect to operative time, blood loss, and hospital stay. The investigator's secondary objective was to assess the cost, morbidity, and mortality of each procedure.
Detailed Description
See Above

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Menorrhagia, Dysfunctional Uterine Bleeding, Leiomyoma, Pelvic Pain, Endometriosis
Keywords
Hysterectomy, Laparoscopy, Robotics

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
98 (Actual)

8. Arms, Groups, and Interventions

Arm Title
LH Group
Arm Type
Active Comparator
Arm Description
The LH Group includes individuals undergoing conventional laparoscopic hysterectomy, total or supracervical.
Arm Title
RH Group
Arm Type
Active Comparator
Arm Description
The RH Group includes individuals undergoing Robot-Assisted laparoscopic hysterectomy, total or supracervical.
Intervention Type
Procedure
Intervention Name(s)
Conventional Laparoscopic Hysterectomy (LH)
Other Intervention Name(s)
LH Group
Intervention Description
Patients assigned to this intervention will undergo conventional laparoscopic hysterectomy, either total or supracervical.
Intervention Type
Procedure
Intervention Name(s)
Robot Assisted Hysterectomy
Other Intervention Name(s)
RH Group
Intervention Description
Patients assigned to this group will undergo Robot-Assisted Laparoscopic Hysterectomy, either total or supracervical.
Primary Outcome Measure Information:
Title
Operating Time
Time Frame
Operating time is measured on the day of surgery after completing the procedure.
Secondary Outcome Measure Information:
Title
Estimated Blood Loss
Time Frame
Estimated blood loss will be measured on the day of surgery after completing the procedure.
Title
Intraoperative Complications
Description
Intraoperative complications include: injury to bladder, ureters, bowel, blood vessels,and nerves AND hemorrhage
Time Frame
Intraoperative complications will be measured on the day of surgery after completing the procedure.
Title
Perioperative Complications
Description
Perioperative complications include: urinary tract infections, urinary retention, ileus, myocardial infarction, atrial fibrillation, pulmonary edema, atelectasis, pneumonia, renal and cerebrovascular morbidity, thromboembolic complications (DVT and PE)
Time Frame
Perioperative complications will be measured on the date of discharge from the hospital.
Title
Early Postoperative Complications
Description
Early postoperative complications include: pulmonary, renal, and cerebrovascular morbidity, wound and vault complications (infection, breakdown, and dehiscence); septicemia, and thromboembolic complications (DVT, PE)
Time Frame
Early postoperative complications will be measured on the date of discharge from the hospital until two weeks after surgery, assessed up to 14 days post-operativley.
Title
Delayed Post-Operative Complications
Description
Delayed post-operative complications include: incisional hernia formation, re-operation, vaginal evisceration
Time Frame
Delayed post-operative complications will be measured from 2 weeks until 8 weeks after surgery, up to 56 days post-operatively.
Title
Costs
Description
Costs will include the costs of pre-operative care, surgery, post-operative care, and any post-operative complications.
Time Frame
Cost will be assessed 8 weeks after completion of the surgery, up to 56 days post-operatively.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Individuals recruited into this study will be patients presenting to the Urogynecology and Minimally Invasive Surgical Group for consultation for hysterectomy. Exclusion Criteria:Individuals who are not candidates for laparoscopic surgery Medical Condition that does not allow pneumoperitoneum Medical Condition that does not allow proper ventilation during anesthesia Uterine size precluding access to the uterine artery Pelvic Organ Prolapse amendable to a vaginal approach
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janis L Green, MD
Organizational Affiliation
Milton S. Hershey Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gerald J Harkins, MD
Organizational Affiliation
Milton S. Hershey Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Matthew Davies, MD
Organizational Affiliation
Milton S. Hershey Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Penn State Milton S. Hershey Medical Center
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21666467
Citation
Sarlos D, Kots LA. Robotic versus laparoscopic hysterectomy: a review of recent comparative studies. Curr Opin Obstet Gynecol. 2011 Aug;23(4):283-8. doi: 10.1097/GCO.0b013e328348a26e.
Results Reference
background
PubMed Identifier
20850391
Citation
Pasic RP, Rizzo JA, Fang H, Ross S, Moore M, Gunnarsson C. Comparing robot-assisted with conventional laparoscopic hysterectomy: impact on cost and clinical outcomes. J Minim Invasive Gynecol. 2010 Nov-Dec;17(6):730-8. doi: 10.1016/j.jmig.2010.06.009. Epub 2010 Sep 17.
Results Reference
background
PubMed Identifier
18439499
Citation
Payne TN, Dauterive FR. A comparison of total laparoscopic hysterectomy to robotically assisted hysterectomy: surgical outcomes in a community practice. J Minim Invasive Gynecol. 2008 May-Jun;15(3):286-91. doi: 10.1016/j.jmig.2008.01.008. Epub 2008 Mar 6.
Results Reference
background
PubMed Identifier
20207063
Citation
Sarlos D, Kots L, Stevanovic N, Schaer G. Robotic hysterectomy versus conventional laparoscopic hysterectomy: outcome and cost analyses of a matched case-control study. Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):92-6. doi: 10.1016/j.ejogrb.2010.02.012. Epub 2010 Mar 5.
Results Reference
background
PubMed Identifier
19793478
Citation
Shashoua AR, Gill D, Locher SR. Robotic-assisted total laparoscopic hysterectomy versus conventional total laparoscopic hysterectomy. JSLS. 2009 Jul-Sep;13(3):364-9.
Results Reference
background

Learn more about this trial

Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution

We'll reach out to this number within 24 hrs